{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:36:04Z","timestamp":1783042564784,"version":"3.54.6"},"reference-count":38,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L212011"],"award-info":[{"award-number":["L212011"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["2022YFC2305303"],"award-info":[{"award-number":["2022YFC2305303"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["L212011"],"award-info":[{"award-number":["L212011"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2305303"],"award-info":[{"award-number":["2022YFC2305303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Factor H-binding protein (fHbp) is a virulence factor expressed by Neisseria meningitidis (N. meningitidis), the primary causative agent of invasive meningococcal disease (IMD) in humans. fHbp is utilized as the main component in vaccines to provide protection against IMD caused by serogroup B N. meningitidis. In order to comprehensively investigate the genetic diversity and epidemiological patterns of fHbp variants within isolates of Chinese N. meningitidis, we utilized the NEIS0349 locus, which encompasses the complete coding sequences of fHbp. This enabled us to identify allelic variants of fHbp with enhanced resolution. A total of 109 fHbp variants were identified in 1013 Chinese N. meningitidis isolates. We reconstructed a phylogenetic tree and analyzed the epidemiological characteristics of each variant. Considering both temporal and geographical distribution patterns, only four fHbp variants (v2.16, v2.18, v2.404, and v2.21) exhibited persistent nationwide prevalence during the previous decade (2011\u20132021). These variants were highly prevalent in both serogroup B strains from patients and healthy individuals, suggesting their potential as suitable vaccine candidates for nationwide implementation against IMD caused by serogroup B strains. Our study emphasizes the significance of conducting continuous surveillance of meningococcal strains to monitor the genetic diversity of fHbp for the purpose of vaccine development.<\/jats:p>","DOI":"10.3390\/microorganisms12030481","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T05:20:32Z","timestamp":1709011232000},"page":"481","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Extensive Genetic Diversity and Epidemiological Patterns of Factor H-Binding Protein Variants among Neisseria meningitidis in China"],"prefix":"10.3390","volume":"12","author":[{"given":"Zhizhou","family":"Tan","sequence":"first","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0473-7942","authenticated-orcid":false,"given":"Jie","family":"Che","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongshan","family":"Yan","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maojun","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5216-6537","authenticated-orcid":false,"given":"Zhujun","family":"Shao","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(21)00883-7","article-title":"Community-acquired bacterial meningitis","volume":"398","author":"Brouwer","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41579-019-0282-6","article-title":"Neisseria meningitidis: Using genomics to understand diversity, evolution and pathogenesis","volume":"18","author":"Caugant","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1080\/21645515.2018.1451810","article-title":"Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development","volume":"14","author":"Dretler","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/iai.63.5.1906-1913.1995","article-title":"Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain","volume":"63","author":"Azmi","year":"1995","journal-title":"Infect. Immun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","article-title":"Functional significance of factor H binding to Neisseria meningitidis","volume":"176","author":"Schneider","year":"2006","journal-title":"J. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sands, N.A., and Beernink, P.T. (2021). Two human antibodies to a meningococcal serogroup B vaccine antigen enhance binding of complement Factor H by stabilizing the Factor H binding site. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009655"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"J. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/MMBR.00056-12","article-title":"Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease","volume":"77","author":"McNeil","year":"2013","journal-title":"Microbiol. Mol. Biol. Rev. MMBR"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4161\/hv.18500","article-title":"Bexsero: A multicomponent vaccine for prevention of meningococcal disease","volume":"8","author":"Gorringe","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_12","first-page":"353","article-title":"Bivalent rLP2086 Vaccine (Trumenba(\u00ae)): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10-25 Years","volume":"29","author":"Shirley","year":"2015","journal-title":"BioDrugs Clin. Immunother. Biopharm. Gene Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1473-3099(22)00424-8","article-title":"Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1\u20139 years: Two phase 2 randomised, controlled, observer-blinded studies","volume":"23","author":"Marshall","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.vaccine.2013.01.021","article-title":"A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults","volume":"31","author":"Marshall","year":"2013","journal-title":"Vaccine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1473-3099(18)30048-3","article-title":"Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: A systematic review and meta-analysis","volume":"18","author":"Flacco","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"ofaa143","DOI":"10.1093\/ofid\/ofaa143","article-title":"Immunogenicity and reactogenicity of a reduced schedule of a 4-component capsular group B meningococcal vaccine: A randomized controlled trial in infants","volume":"7","author":"Galal","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.vaccine.2009.12.027","article-title":"Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates","volume":"28","author":"Pajon","year":"2010","journal-title":"Vaccine"},{"key":"ref_18","first-page":"30084","article-title":"Meningococcal vaccine antigen diversity in global databases","volume":"20","author":"Brehony","year":"2015","journal-title":"Euro Surveill. Bull. Eur. Sur Les Mal. Transm. Eur. Commun. Dis. Bull."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1016\/j.vaccine.2020.04.074","article-title":"High genomic-based predicted strain coverage among invasive meningococcal isolates when combining Bexsero and Trumenba vaccines","volume":"38","author":"Olofsson","year":"2020","journal-title":"Vaccine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.vaccine.2017.03.057","article-title":"Prevalence of factor H binding protein sub-variants among Neisseria meningitidis in China","volume":"35","author":"Shi","year":"2017","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Watkins, E.R., and Maiden, M.C.J. (2012). Persistence of hyperinvasive meningococcal strain types during global spread as recorded in the pubMLST database. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045349"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Bratcher, H.B., Corton, C., Jolley, K.A., Parkhill, J., and Maiden, M.C. (2014). A gene-by-gene population genomics platform: De novo assembly, annotation and genealogical analysis of 108 representative Neisseria meningitidis genomes. BMC Genom., 15.","DOI":"10.1186\/1471-2164-15-1138"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/00325481.2016.1203238","article-title":"Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba\u00ae)","volume":"128","author":"Gandhi","year":"2016","journal-title":"Postgrad. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"D785","DOI":"10.1093\/nar\/gkab776","article-title":"GTDB: An ongoing census of bacterial and archaeal diversity through a phylogenetically consistent, rank normalized and complete genome-based taxonomy","volume":"50","author":"Parks","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1101\/gr.186072.114","article-title":"CheckM: Assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes","volume":"25","author":"Parks","year":"2015","journal-title":"Genome Res."},{"key":"ref_26","first-page":"e000166","article-title":"chewBBACA: A complete suite for gene-by-gene schema creation and strain identification","volume":"4","author":"Silva","year":"2018","journal-title":"Microb. Genom."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v017.i03","article-title":"The strucplot framework: Visualizing multi-way contingency tables with vcd","volume":"17","author":"Meyer","year":"2006","journal-title":"J. Stat. Softw."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","article-title":"IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era","volume":"37","author":"Minh","year":"2020","journal-title":"Mol. Biol. Evol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1002\/cpbi.96","article-title":"Using ggtree to visualize data on tree-like structures","volume":"69","author":"Yu","year":"2020","journal-title":"Curr. Protoc. Bioinform."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1093\/molbev\/msab166","article-title":"ggtreeExtra: Compact visualization of richly annotated phylogenetic data","volume":"38","author":"Xu","year":"2021","journal-title":"Mol. Biol. Evol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Yue, M., Xu, J., Yu, J., and Shao, Z. (2022). Carriage prevalence of Neisseria meningitidis in China, 2005\u20132022: A systematic review and meta-analysis. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07586-x"},{"key":"ref_32","first-page":"159","article-title":"Analysis of epidemic characteristics for meningococcal meningitis in China during 2015\u20132017","volume":"53","author":"Li","year":"2019","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi [Chin. J. Prev. Med.]"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2071077","DOI":"10.1080\/21645515.2022.2071077","article-title":"Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010\u20132020: A systematic review and meta-analysis","volume":"18","author":"Xu","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1080\/21645515.2020.1857201","article-title":"Meningococcal vaccines in China","volume":"17","author":"Xu","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Pizza, M., Bekkat-Berkani, R., and Rappuoli, R. (2020). Vaccines against Meningococcal Diseases. Microorganisms, 8.","DOI":"10.3390\/microorganisms8101521"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"00751","DOI":"10.3389\/fimmu.2019.00751","article-title":"The development of a vaccine against meningococcus B using reverse vaccinology","volume":"10","author":"Masignani","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.vaccine.2018.12.061","article-title":"Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide","volume":"37","author":"Muzzi","year":"2019","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jinf.2018.01.007","article-title":"Meningococcal disease and control in China: Findings and updates from the Global Meningococcal Initiative (GMI)","volume":"76","author":"Li","year":"2018","journal-title":"J. Infect."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/3\/481\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:05:36Z","timestamp":1760105136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/3\/481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["microorganisms12030481"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms12030481","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]}}}